Has the FROSTBITE-2 trial changed how you choose between cryoprobe and forceps for transbronchial biopsy in your practice?
Thiboutot et al., PMID 42149700
1 Answer
Mednet MemberInvited Expert
Pulmonology · University of Maryland Medical School
Answered on
FROSTBITE - 2 trial suggested that cryobiopsy was associated with a high diagnostic yield and a satisfactory safety profile. Overall, cryobiopsy using the 1.1 mm cryoprobe for nodules, ILD, and post-transplant biopsy would be my first choice.
Join for free or sign in to see the full answer